Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.

Targeting the Kv1.3 potassium channel has proven effective in reducing obesity and the severity of animal models of autoimmune disease. Stichodactyla toxin (ShK), isolated from the sea anemone Stichodactyla helianthus, is a potent blocker of Kv1.3. Several of its analogs are some of the most potent...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuqing Wang, Ayrea Hurley, Marco De Giorgi, Mark R Tanner, Rong-Chi Hu, Michael W Pennington, William R Lagor, Christine Beeton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283996&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589885597286400
author Yuqing Wang
Ayrea Hurley
Marco De Giorgi
Mark R Tanner
Rong-Chi Hu
Michael W Pennington
William R Lagor
Christine Beeton
author_facet Yuqing Wang
Ayrea Hurley
Marco De Giorgi
Mark R Tanner
Rong-Chi Hu
Michael W Pennington
William R Lagor
Christine Beeton
author_sort Yuqing Wang
collection DOAJ
description Targeting the Kv1.3 potassium channel has proven effective in reducing obesity and the severity of animal models of autoimmune disease. Stichodactyla toxin (ShK), isolated from the sea anemone Stichodactyla helianthus, is a potent blocker of Kv1.3. Several of its analogs are some of the most potent and selective blockers of this channel. However, like most biologics, ShK and its analogs require injections for their delivery, and repeated injections reduce patient compliance during the treatment of chronic diseases. We hypothesized that inducing the expression of an ShK analog by hepatocytes would remove the requirement for frequent injections and lead to a sustained level of Kv1.3 blocker in the circulation. To this goal, we tested the ability of Adeno-Associated Virus (AAV)8 vectors to target hepatocytes for expressing the ShK analog, ShK-235 (AAV-ShK-235) in rodents. We designed AAV8 vectors expressing the target transgene, ShK-235, or Enhanced Green fluorescent protein (EGFP). Transduction of mouse livers led to the production of sufficient levels of functional ShK-235 in the serum from AAV-ShK-235 single-injected mice to block Kv1.3 channels. However, AAV-ShK-235 therapy was not effective in reducing high-fat diet-induced obesity in mice. In addition, injection of even high doses of AAV8-ShK-235 to rats resulted in a very low liver transduction efficiency and failed to reduce inflammation in a well-established rat model of delayed-type hypersensitivity. In conclusion, the AAV8-based delivery of ShK-235 was highly effective in inducing the secretion of functional Kv1.3-blocking peptide in mouse, but not rat, hepatocytes yet did not reduce obesity in mice fed a high-fat diet.
format Article
id doaj-art-07bb24c77595445685048ba486dfdb66
institution Kabale University
issn 1932-6203
language English
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-07bb24c77595445685048ba486dfdb662025-01-24T05:31:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e028399610.1371/journal.pone.0283996Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.Yuqing WangAyrea HurleyMarco De GiorgiMark R TannerRong-Chi HuMichael W PenningtonWilliam R LagorChristine BeetonTargeting the Kv1.3 potassium channel has proven effective in reducing obesity and the severity of animal models of autoimmune disease. Stichodactyla toxin (ShK), isolated from the sea anemone Stichodactyla helianthus, is a potent blocker of Kv1.3. Several of its analogs are some of the most potent and selective blockers of this channel. However, like most biologics, ShK and its analogs require injections for their delivery, and repeated injections reduce patient compliance during the treatment of chronic diseases. We hypothesized that inducing the expression of an ShK analog by hepatocytes would remove the requirement for frequent injections and lead to a sustained level of Kv1.3 blocker in the circulation. To this goal, we tested the ability of Adeno-Associated Virus (AAV)8 vectors to target hepatocytes for expressing the ShK analog, ShK-235 (AAV-ShK-235) in rodents. We designed AAV8 vectors expressing the target transgene, ShK-235, or Enhanced Green fluorescent protein (EGFP). Transduction of mouse livers led to the production of sufficient levels of functional ShK-235 in the serum from AAV-ShK-235 single-injected mice to block Kv1.3 channels. However, AAV-ShK-235 therapy was not effective in reducing high-fat diet-induced obesity in mice. In addition, injection of even high doses of AAV8-ShK-235 to rats resulted in a very low liver transduction efficiency and failed to reduce inflammation in a well-established rat model of delayed-type hypersensitivity. In conclusion, the AAV8-based delivery of ShK-235 was highly effective in inducing the secretion of functional Kv1.3-blocking peptide in mouse, but not rat, hepatocytes yet did not reduce obesity in mice fed a high-fat diet.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283996&type=printable
spellingShingle Yuqing Wang
Ayrea Hurley
Marco De Giorgi
Mark R Tanner
Rong-Chi Hu
Michael W Pennington
William R Lagor
Christine Beeton
Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
PLoS ONE
title Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
title_full Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
title_fullStr Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
title_full_unstemmed Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
title_short Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
title_sort adeno associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283996&type=printable
work_keys_str_mv AT yuqingwang adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT ayreahurley adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT marcodegiorgi adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT markrtanner adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT rongchihu adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT michaelwpennington adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT williamrlagor adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver
AT christinebeeton adenoassociatedvirus8deliversanimmunomodulatorypeptidetomouselivermoreefficientlythantoratliver